What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: TechNavio | PRODUCT CODE: 1762973

PUBLISHER: TechNavio | PRODUCT CODE: 1762973

Global Leuprolide Acetate Market 2025-2029

PUBLISHED: June 21, 2025

PAGES: 198 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The leuprolide acetate market is forecasted to grow by USD 1,713.7 mn during 2024-2029, accelerating at a CAGR of 10.5% during the forecast period. The report on the leuprolide acetate market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of prostate cancer, rising availability of funds for research and development, and increasing healthcare expenditures and growing geriatric population.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	9.4%
CAGR	10.5%
Incremental Value	$1,713.7 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's leuprolide acetate market is segmented as below:

By End-user

Hospitals
Clinics
Research and academic institiutions

By Route Of Administration

Intramuscular
Subcutaneous
Intranasal
Implantation

By Product Type

Pre-filled syringes
Vials
Lyophilized powder

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the popularity of novel drug delivery systems as one of the prime reasons driving the leuprolide acetate market growth during the next few years. Also, increasing strategic alliances and advent of targeted therapies will lead to sizable demand in the market.

The report on the leuprolide acetate market covers the following areas:

Leuprolide Acetate Market sizing
Leuprolide Acetate Market forecast
Leuprolide Acetate Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading leuprolide acetate market vendors that include AbbVie Inc., Aspen Oss B.V., Astellas Pharma Inc., Bachem AG, Beijing Biote Pharmaceutical Co. Ltd., Ferring BV, LG Chem Ltd., Livzon Pharmaceutical Group Inc., Merck KGaA, Midas Pharma GmbH, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Tolmar Pharmaceuticals Inc.. Also, the leuprolide acetate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR71763

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Leuprolide Acetate Market 2019 - 2023
- Historic Market Size - Data Table on Global Leuprolide Acetate Market 2019 - 2023 ($ million)
5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Leuprolide Acetate Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Clinics - Market size and forecast 2024-2029
- Chart on Clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Clinics - Year-over-year growth 2024-2029 (%)
8.5 Research and academic institiutions - Market size and forecast 2024-2029
- Chart on Research and academic institiutions - Market size and forecast 2024-2029 ($ million)
- Data Table on Research and academic institiutions - Market size and forecast 2024-2029 ($ million)
- Chart on Research and academic institiutions - Year-over-year growth 2024-2029 (%)
- Data Table on Research and academic institiutions - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
9.3 Intramuscular - Market size and forecast 2024-2029
- Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
- Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
- Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
- Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
9.4 Subcutaneous - Market size and forecast 2024-2029
- Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
9.5 Intranasal - Market size and forecast 2024-2029
- Chart on Intranasal - Market size and forecast 2024-2029 ($ million)
- Data Table on Intranasal - Market size and forecast 2024-2029 ($ million)
- Chart on Intranasal - Year-over-year growth 2024-2029 (%)
- Data Table on Intranasal - Year-over-year growth 2024-2029 (%)
9.6 Implantation - Market size and forecast 2024-2029
- Chart on Implantation - Market size and forecast 2024-2029 ($ million)
- Data Table on Implantation - Market size and forecast 2024-2029 ($ million)
- Chart on Implantation - Year-over-year growth 2024-2029 (%)
- Data Table on Implantation - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Product Type

10.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
10.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
10.3 Pre-filled syringes - Market size and forecast 2024-2029
- Chart on Pre-filled syringes - Market size and forecast 2024-2029 ($ million)
- Data Table on Pre-filled syringes - Market size and forecast 2024-2029 ($ million)
- Chart on Pre-filled syringes - Year-over-year growth 2024-2029 (%)
- Data Table on Pre-filled syringes - Year-over-year growth 2024-2029 (%)
10.4 Vials - Market size and forecast 2024-2029
- Chart on Vials - Market size and forecast 2024-2029 ($ million)
- Data Table on Vials - Market size and forecast 2024-2029 ($ million)
- Chart on Vials - Year-over-year growth 2024-2029 (%)
- Data Table on Vials - Year-over-year growth 2024-2029 (%)
10.5 Lyophilized powder - Market size and forecast 2024-2029
- Chart on Lyophilized powder - Market size and forecast 2024-2029 ($ million)
- Data Table on Lyophilized powder - Market size and forecast 2024-2029 ($ million)
- Chart on Lyophilized powder - Year-over-year growth 2024-2029 (%)
- Data Table on Lyophilized powder - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Aspen Oss B.V.
- Aspen Oss B.V. - Overview
- Aspen Oss B.V. - Product / Service
- Aspen Oss B.V. - Key offerings
- SWOT
15.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.7 Bachem AG
- Bachem AG - Overview
- Bachem AG - Business segments
- Bachem AG - Key offerings
- Bachem AG - Segment focus
- SWOT
15.8 Beijing Biote Pharmaceutical Co. Ltd.
- Beijing Biote Pharmaceutical Co. Ltd. - Overview
- Beijing Biote Pharmaceutical Co. Ltd. - Product / Service
- Beijing Biote Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.9 Ferring BV
- Ferring BV - Overview
- Ferring BV - Product / Service
- Ferring BV - Key news
- Ferring BV - Key offerings
- SWOT
15.10 LG Chem Ltd.
- LG Chem Ltd. - Overview
- LG Chem Ltd. - Business segments
- LG Chem Ltd. - Key news
- LG Chem Ltd. - Key offerings
- LG Chem Ltd. - Segment focus
- SWOT
15.11 Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. - Overview
- Livzon Pharmaceutical Group Inc. - Product / Service
- Livzon Pharmaceutical Group Inc. - Key offerings
- SWOT
15.12 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
15.13 Midas Pharma GmbH
- Midas Pharma GmbH - Overview
- Midas Pharma GmbH - Product / Service
- Midas Pharma GmbH - Key offerings
- SWOT
15.14 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.15 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.16 Tolmar Pharmaceuticals Inc.
- Tolmar Pharmaceuticals Inc. - Overview
- Tolmar Pharmaceuticals Inc. - Product / Service
- Tolmar Pharmaceuticals Inc. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR71763

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Leuprolide Acetate Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on End-user - Market share 2024-2029 (%)
Exhibits39: Data Table on End-user - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by End-user
Exhibits41: Data Table on Comparison by End-user
Exhibits42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Research and academic institiutions - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Research and academic institiutions - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Research and academic institiutions - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Research and academic institiutions - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by End-user ($ million)
Exhibits55: Data Table on Market opportunity by End-user ($ million)
Exhibits56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Intranasal - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Intranasal - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Intranasal - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Intranasal - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Implantation - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Implantation - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Implantation - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Implantation - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Route of Administration ($ million)
Exhibits77: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits78: Chart on Product Type - Market share 2024-2029 (%)
Exhibits79: Data Table on Product Type - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by Product Type
Exhibits81: Data Table on Comparison by Product Type
Exhibits82: Chart on Pre-filled syringes - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Pre-filled syringes - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Pre-filled syringes - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Pre-filled syringes - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Vials - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Vials - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Vials - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Vials - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Lyophilized powder - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on Lyophilized powder - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on Lyophilized powder - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Lyophilized powder - Year-over-year growth 2024-2029 (%)
Exhibits94: Market opportunity by Product Type ($ million)
Exhibits95: Data Table on Market opportunity by Product Type ($ million)
Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits99: Chart on Geographic comparison
Exhibits100: Data Table on Geographic comparison
Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits157: Market opportunity By Geographical Landscape ($ million)
Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits159: Impact of drivers and challenges in 2024 and 2029
Exhibits160: Overview on criticality of inputs and factors of differentiation
Exhibits161: Overview on factors of disruption
Exhibits162: Impact of key risks on business
Exhibits163: Companies covered
Exhibits164: Company ranking index
Exhibits165: Matrix on companies position and classification
Exhibits166: AbbVie Inc. - Overview
Exhibits167: AbbVie Inc. - Product / Service
Exhibits168: AbbVie Inc. - Key news
Exhibits169: AbbVie Inc. - Key offerings
Exhibits170: SWOT
Exhibits171: Aspen Oss B.V. - Overview
Exhibits172: Aspen Oss B.V. - Product / Service
Exhibits173: Aspen Oss B.V. - Key offerings
Exhibits174: SWOT
Exhibits175: Astellas Pharma Inc. - Overview
Exhibits176: Astellas Pharma Inc. - Product / Service
Exhibits177: Astellas Pharma Inc. - Key offerings
Exhibits178: SWOT
Exhibits179: Bachem AG - Overview
Exhibits180: Bachem AG - Business segments
Exhibits181: Bachem AG - Key offerings
Exhibits182: Bachem AG - Segment focus
Exhibits183: SWOT
Exhibits184: Beijing Biote Pharmaceutical Co. Ltd. - Overview
Exhibits185: Beijing Biote Pharmaceutical Co. Ltd. - Product / Service
Exhibits186: Beijing Biote Pharmaceutical Co. Ltd. - Key offerings
Exhibits187: SWOT
Exhibits188: Ferring BV - Overview
Exhibits189: Ferring BV - Product / Service
Exhibits190: Ferring BV - Key news
Exhibits191: Ferring BV - Key offerings
Exhibits192: SWOT
Exhibits193: LG Chem Ltd. - Overview
Exhibits194: LG Chem Ltd. - Business segments
Exhibits195: LG Chem Ltd. - Key news
Exhibits196: LG Chem Ltd. - Key offerings
Exhibits197: LG Chem Ltd. - Segment focus
Exhibits198: SWOT
Exhibits199: Livzon Pharmaceutical Group Inc. - Overview
Exhibits200: Livzon Pharmaceutical Group Inc. - Product / Service
Exhibits201: Livzon Pharmaceutical Group Inc. - Key offerings
Exhibits202: SWOT
Exhibits203: Merck KGaA - Overview
Exhibits204: Merck KGaA - Business segments
Exhibits205: Merck KGaA - Key news
Exhibits206: Merck KGaA - Key offerings
Exhibits207: Merck KGaA - Segment focus
Exhibits208: SWOT
Exhibits209: Midas Pharma GmbH - Overview
Exhibits210: Midas Pharma GmbH - Product / Service
Exhibits211: Midas Pharma GmbH - Key offerings
Exhibits212: SWOT
Exhibits213: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits214: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits215: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits216: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits217: SWOT
Exhibits218: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits219: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits220: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits221: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits222: SWOT
Exhibits223: Tolmar Pharmaceuticals Inc. - Overview
Exhibits224: Tolmar Pharmaceuticals Inc. - Product / Service
Exhibits225: Tolmar Pharmaceuticals Inc. - Key offerings
Exhibits226: SWOT
Exhibits227: Inclusions checklist
Exhibits228: Exclusions checklist
Exhibits229: Currency conversion rates for US$
Exhibits230: Research methodology
Exhibits231: Information sources
Exhibits232: Data validation
Exhibits233: Validation techniques employed for market sizing
Exhibits234: Data synthesis
Exhibits235: 360 degree market analysis
Exhibits236: List of abbreviations